-
1
-
-
51649096593
-
The genetics of clinical outcome in multiple sclerosis
-
Ramagopalan SV, Deluca GC, Degenhardt A, et al. The genetics of clinical outcome in multiple sclerosis. J Neuroimmunol 2008;201-202:183-99.
-
(2008)
J Neuroimmunol
, vol.201-202
, pp. 183-199
-
-
Ramagopalan, S.V.1
Deluca, G.C.2
Degenhardt, A.3
-
2
-
-
0036326151
-
Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis
-
DOI 10.1034/j.1600-0404.2002.01334.x
-
Giubilei F, Antonini G, Di Legge S, et al. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand 2002;106:109-12. (Pubitemid 34831927)
-
(2002)
Acta Neurologica Scandinavica
, vol.106
, Issue.2
, pp. 109-112
-
-
Giubilei, F.1
Antonini, G.2
Di, L.S.3
Sormani, M.P.4
Pantano, P.5
Antonini, R.6
Sepe-Monti, M.7
Caramia, F.8
Pozzilli, C.9
-
3
-
-
84885649688
-
Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event
-
Weinstock-Guttman B, Zivadinov R, Horakova D, et al. Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event. J Neurol Neurosurg Psychiatry 2013;84:1186-91.
-
(2013)
J Neurol Neurosurg Psychiatry
, vol.84
, pp. 1186-1191
-
-
Weinstock-Guttman, B.1
Zivadinov, R.2
Horakova, D.3
-
4
-
-
80053550020
-
Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
-
Weinstock-Guttman B, Zivadinov R, Mahfooz N, et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation 2011;8:127.
-
(2011)
J Neuroinflammation
, vol.8
, pp. 127
-
-
Weinstock-Guttman, B.1
Zivadinov, R.2
Mahfooz, N.3
-
5
-
-
77950209814
-
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis
-
Marrie RA, Rudick R, Horwitz R, et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 2010;74:1041-7.
-
(2010)
Neurology
, vol.74
, pp. 1041-1047
-
-
Marrie, R.A.1
Rudick, R.2
Horwitz, R.3
-
6
-
-
81255135976
-
Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis
-
Weinstock-Guttman B, Zivadinov R, Ramanathan M. Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis. J Neurol Sci 2011;311:86-91.
-
(2011)
J Neurol Sci
, vol.311
, pp. 86-91
-
-
Weinstock-Guttman, B.1
Zivadinov, R.2
Ramanathan, M.3
-
7
-
-
84884812196
-
Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes
-
Weinstock-Guttman B, Horakova D, Zivadinov R, et al. Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes. J Neuroimmunol 2013;263:121-7.
-
(2013)
J Neuroimmunol
, vol.263
, pp. 121-127
-
-
Weinstock-Guttman, B.1
Horakova, D.2
Zivadinov, R.3
-
8
-
-
40749121688
-
The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment
-
DOI 10.1111/j.1463-1326.2007.00714.x
-
Andrikoula M, McDowell IF. The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment. Diabetes Obes Metab 2008;10:271-8. (Pubitemid 351386024)
-
(2008)
Diabetes, Obesity and Metabolism
, vol.10
, Issue.4
, pp. 271-278
-
-
Andrikoula, M.1
Mcdowell, I.F.W.2
-
9
-
-
46449096115
-
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment
-
Kastelein JJ, van der Steeg WA, Holme I, et al. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation 2008;117:3002-9.
-
(2008)
Circulation
, vol.117
, pp. 3002-3009
-
-
Kastelein, J.J.1
Van Der Steeg, W.A.2
Holme, I.3
-
10
-
-
34250208462
-
Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke
-
DOI 10.1097/HCO.0b013e3281bd8849, PII 0000157320070700000016
-
Walldius G, Jungner I. Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke. Curr Opin Cardiol 2007;22:359-67. (Pubitemid 46897289)
-
(2007)
Current Opinion in Cardiology
, vol.22
, Issue.4
, pp. 359-367
-
-
Walldius, G.1
Jungner, I.2
-
11
-
-
0031032472
-
ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion
-
Pussinen PJ, Jauhiainen M, Ehnholm C. ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion. J Lipid Res 1997;38:12-21. (Pubitemid 27097070)
-
(1997)
Journal of Lipid Research
, vol.38
, Issue.1
, pp. 12-21
-
-
Pussinen, P.J.1
Jauhiainen, M.2
Ehnholm, C.3
-
12
-
-
48149087776
-
HDL-cholesterol: Is it really good?: Differences between apoA-I and HDL
-
Santos-Gallego CG, Ibanez B, Badimon JJ. HDL-cholesterol: Is it really good?: Differences between apoA-I and HDL. Biochem Pharmacol 2008;76:443-52.
-
(2008)
Biochem Pharmacol
, vol.76
, pp. 443-452
-
-
Santos-Gallego, C.G.1
Ibanez, B.2
Badimon, J.J.3
-
13
-
-
33645422718
-
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL
-
Zannis V, Chroni A, Krieger M. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med 2006;84:276-94.
-
(2006)
J Mol Med
, vol.84
, pp. 276-294
-
-
Zannis, V.1
Chroni, A.2
Krieger, M.3
-
14
-
-
80053390838
-
ApoE controls the interface linking lipids and inflammation in atherosclerosis
-
Weber C, Soehnlein O. ApoE controls the interface linking lipids and inflammation in atherosclerosis. J Clin Invest 2011;121:3825-7.
-
(2011)
J Clin Invest
, vol.121
, pp. 3825-3827
-
-
Weber, C.1
Soehnlein, O.2
-
15
-
-
77953518270
-
The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis
-
Zhang HL, Wu J, Zhu J. The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Dev Immunol 2010;2010:186813..
-
(2010)
Clin Dev Immunol
, vol.2010
, pp. 186813
-
-
Zhang, H.L.1
Wu, J.2
Zhu, J.3
-
16
-
-
84863504256
-
Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease
-
Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med 2012;2:a006312.
-
(2012)
Cold Spring Harb Perspect Med
, vol.2
-
-
Holtzman, D.M.1
Herz, J.2
Bu, G.3
-
17
-
-
84869209204
-
Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: A longitudinal cohort study
-
Kalincik T, Vaneckova M, Tyblova M, et al. Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study. PloS ONE 2012;7:e50101.
-
(2012)
PloS ONE
, vol.7
-
-
Kalincik, T.1
Vaneckova, M.2
Tyblova, M.3
-
18
-
-
84872203150
-
Environmental factors associated with disease progression after the first demyelinating event: Results from the multi-center SET study
-
Horakova D, Zivadinov R, Weinstock-Guttman B, et al. Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study. PloS ONE 2013;8:e53996.
-
(2013)
PloS ONE
, vol.8
-
-
Horakova, D.1
Zivadinov, R.2
Weinstock-Guttman, B.3
-
19
-
-
80054106754
-
Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: A case-control study
-
Zivadinov R, Heininen-Brown M, Schirda CV, et al. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. NeuroImage 2012;59:331-9.
-
(2012)
NeuroImage
, vol.59
, pp. 331-339
-
-
Zivadinov, R.1
Heininen-Brown, M.2
Schirda, C.V.3
-
20
-
-
0036742197
-
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
-
Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 2002;17:479-89.
-
(2002)
NeuroImage
, vol.17
, pp. 479-489
-
-
Smith, S.M.1
Zhang, Y.2
Jenkinson, M.3
-
21
-
-
79955484518
-
A Bayesian model of shape and appearance for subcortical brain segmentation
-
Patenaude B, Smith SM, Kennedy DN, et al. A Bayesian model of shape and appearance for subcortical brain segmentation. NeuroImage 2011;56:907-22.
-
(2011)
NeuroImage
, vol.56
, pp. 907-922
-
-
Patenaude, B.1
Smith, S.M.2
Kennedy, D.N.3
-
22
-
-
84883183367
-
Thalamic atrophy is associated with development of clinically definite multiple sclerosis
-
Zivadinov R, Havrdova E, Bergsland N, et al. Thalamic atrophy is associated with development of clinically definite multiple sclerosis. Radiology 2013;268:831-41.
-
(2013)
Radiology
, vol.268
, pp. 831-841
-
-
Zivadinov, R.1
Havrdova, E.2
Bergsland, N.3
-
23
-
-
34548124618
-
Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I - new risk factors and targets for therapy
-
DOI 10.1016/j.numecd.2007.02.010, PII S0939475307000567
-
Walldius G, Jungner I. Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I-new risk factors and targets for therapy. Nutr, Metab Cardiovasc Dis 2007;17:565-71. (Pubitemid 47302307)
-
(2007)
Nutrition, Metabolism and Cardiovascular Diseases
, vol.17
, Issue.8
, pp. 565-571
-
-
Walldius, G.1
Jungner, I.2
-
25
-
-
49049090627
-
Apolipoprotein E-mediated immune regulation in sepsis
-
Kattan OM, Kasravi FB, Elford EL, et al. Apolipoprotein E-mediated immune regulation in sepsis. J Immunol 2008;181:1399-408.
-
(2008)
J Immunol
, vol.181
, pp. 1399-1408
-
-
Kattan, O.M.1
Kasravi, F.B.2
Elford, E.L.3
-
26
-
-
84858423000
-
Reducing human apolipoprotein E levels attenuates age-dependent Abeta accumulation in mutant human amyloid precursor protein transgenic mice
-
Bien-Ly N, Gillespie AK, Walker D, et al. Reducing human apolipoprotein E levels attenuates age-dependent Abeta accumulation in mutant human amyloid precursor protein transgenic mice. J Neuroscience2012;32:4803-11.
-
(2012)
J Neuroscience
, vol.32
, pp. 4803-4811
-
-
Bien-Ly, N.1
Gillespie, A.K.2
Walker, D.3
-
27
-
-
33745584625
-
ApoE plasma levels and risk of cardiovascular mortality in old age
-
Mooijaart SP, Berbee JF, van Heemst D, et al. ApoE plasma levels and risk of cardiovascular mortality in old age. PLoS Med 2006;3:e176.
-
(2006)
PLoS Med
, vol.3
-
-
Mooijaart, S.P.1
Berbee, J.F.2
Van Heemst, D.3
-
28
-
-
84870262595
-
Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects
-
Lill CM, Liu T, Schjeide BM, et al. Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. J Med Genet 2012;49:558-62.
-
(2012)
J Med Genet
, vol.49
, pp. 558-562
-
-
Lill, C.M.1
Liu, T.2
Schjeide, B.M.3
-
29
-
-
33745043269
-
The association between apolipoprotein E and multiple sclerosis
-
DOI 10.1111/j.1468-1331.2006.01360.x
-
Pinholt M, Frederiksen JL, Christiansen M. The association between apolipoprotein E and multiple sclerosis. Eur J Neurol 2006;13:573-80. (Pubitemid 43873629)
-
(2006)
European Journal of Neurology
, vol.13
, Issue.6
, pp. 573-580
-
-
Pinholt, M.1
Frederiksen, J.L.2
Christiansen, M.3
-
30
-
-
0023205122
-
Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination
-
Rifai N, Christenson RH, Gelman BB, et al. Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination. Clin Chem 1987;33:1155-7. (Pubitemid 17157906)
-
(1987)
Clinical Chemistry
, vol.33
, Issue.7
, pp. 1155-1157
-
-
Rifai, N.1
Christenson, R.H.2
Gelman, B.B.3
Silverman, L.M.4
-
31
-
-
0023828765
-
Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis
-
Gelman BB, Rifai N, Christenson RH, et al. Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis. Ann Clin Lab Sci 1988;18:46-52. (Pubitemid 18073103)
-
(1988)
Annals of Clinical and Laboratory Science
, vol.18
, Issue.1
, pp. 46-52
-
-
Gelman, B.B.1
Rifai, N.2
Christenson, R.H.3
Silverman, L.M.4
-
32
-
-
0032581174
-
Apolipoprotein E and multiple sclerosis: A biochemical and genetic investigation
-
DOI 10.1016/S0022-510X(98)00118-X, PII S0022510X9800118X
-
Gaillard O, Gervais A, Meillet D, et al. Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation. J Neurol Sci 1998;158:180-6. (Pubitemid 28342082)
-
(1998)
Journal of the Neurological Sciences
, vol.158
, Issue.2
, pp. 180-186
-
-
Gaillard, O.1
Gervais, A.2
Meillet, D.3
Plassart, E.4
Fontaine, B.5
Lyon-Caen, O.6
Delattre, J.7
Schuller, E.8
-
33
-
-
0033943488
-
Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster
-
DOI 10.1034/j.1600-0404.2000.102002094.x
-
Pirttila T, Haanpaa M, Mehta PD, et al. Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster. Acta Neurol Scand 2000;102:94-8. (Pubitemid 30469502)
-
(2000)
Acta Neurologica Scandinavica
, vol.102
, Issue.2
, pp. 94-98
-
-
Pirttila, T.1
Haanpaa, M.2
Mehta, P.D.3
Lehtimaki, T.4
-
34
-
-
84873047379
-
Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis
-
Dayger CA, Rosenberg JS, Winkler C, et al. Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis. Pharmacol Biochem Behav 2013;103:860-8.
-
(2013)
Pharmacol Biochem Behav
, vol.103
, pp. 860-868
-
-
Dayger, C.A.1
Rosenberg, J.S.2
Winkler, C.3
-
35
-
-
79959340773
-
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
-
Christoffersen C, Obinata H, Kumaraswamy SB, et al. Endothelium- protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci USA 2011;108:9613-8.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 9613-9618
-
-
Christoffersen, C.1
Obinata, H.2
Kumaraswamy, S.B.3
-
36
-
-
36049034200
-
Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice
-
DOI 10.1161/ATVBAHA.107.149476, PII 0004360520071100000018
-
Klingenberg R, Nofer JR, Rudling M, et al. Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2007;27:2392-9. (Pubitemid 350203955)
-
(2007)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.27
, Issue.11
, pp. 2392-2399
-
-
Klingenberg, R.1
Nofer, J.-R.2
Rudling, M.3
Bea, F.4
Blessing, E.5
Preusch, M.6
Grone, H.J.7
Katus, H.A.8
Hansson, G.K.9
Dengler, T.J.10
-
37
-
-
33846688688
-
FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice
-
DOI 10.1161/CIRCULATIONAHA.106.641407, PII 0000301720070130000013
-
Nofer JR, Bot M, Brodde M, et al. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2007;115:501-8. (Pubitemid 46188244)
-
(2007)
Circulation
, vol.115
, Issue.4
, pp. 501-508
-
-
Nofer, J.-R.1
Bot, M.2
Brodde, M.3
Taylor, P.J.4
Salm, P.5
Brinkmann, V.6
Van Berkel, T.7
Assmann, G.8
Biessen, E.A.L.9
-
38
-
-
79960341237
-
Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): A placebo-controlled randomised phase 4 trial
-
Sorensen PS, Lycke J, Eralinna JP, et al. Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial. Lancet Neurol 2011;10:691-701.
-
(2011)
Lancet Neurol
, vol.10
, pp. 691-701
-
-
Sorensen, P.S.1
Lycke, J.2
Eralinna, J.P.3
-
39
-
-
84860723016
-
Randomized controlled trial of atorvastatin in clinically isolated syndrome: The STAyCIS study
-
Waubant E, Pelletier D, Mass M, et al. Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology 2012;78:1171-8.
-
(2012)
Neurology
, vol.78
, pp. 1171-1178
-
-
Waubant, E.1
Pelletier, D.2
Mass, M.3
|